{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Myositis is an autoimmune disease that causes persistent muscle swelling, inflammation and weakness, as well as other complications. ", "headline": {"seo": "Myositis: An Elusive Diagnosis, and One That Comes With a Risk of Cancer", "main": "An Elusive Diagnosis, and One That Comes With a Risk of Cancer", "print_headline": "An Elusive Diagnosis, and One That Comes With a Risk of Cancer"}, "abstract": null, "print_page": "5", "word_count": "1394", "_id": "54908db679881035eeb2e15c", "snippet": "Myositis is an autoimmune disease that causes persistent muscle swelling, inflammation and weakness, as well as other complications.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/03/27/health/27immu.html", "multimedia": [{"subtype": "xlarge", "url": "images/2007/03/27/science/immu.600.jpg", "height": 314, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2007/03/27/science/immu.600.jpg", "xlargeheight": "314"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2007/03/27/science/immu.7575.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2007/03/27/science/immu.7575.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Medicine and Health", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Cancer", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Arthritis and Rheumatism", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Immune System", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"firstname": "Roni", "middlename": "Caryn", "lastname": "RABIN", "rank": 1, "role": "reported", "organization": ""}], "original": "By RONI CARYN RABIN"}, "document_type": "article", "pub_date": "2007-03-27T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Beckman Coulter will acquire Biosite, a smaller maker of diagnostic blood tests, for about $1.55 billion.", "headline": {"main": "Distributor of Medical Test to Buy a Rival", "print_headline": "Distributor Of Medical Test To Buy a Rival"}, "abstract": null, "print_page": "8", "word_count": "267", "_id": "549089af79881035eeb2e0d5", "snippet": "Beckman Coulter will acquire Biosite, a smaller maker of diagnostic blood tests, for about $1.55 billion.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/03/26/business/26deal.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Beckman Coulter Incorporated", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [{"firstname": "Michael", "middlename": "J.", "lastname": "DE LA MERCED", "rank": 1, "role": "reported", "organization": ""}], "original": "By MICHAEL J. DE LA MERCED"}, "document_type": "article", "pub_date": "2007-03-26T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine", "lead_paragraph": "Why are poor countries subsidizing rich ones?", "headline": {"seo": "Globalization - Developing Countries - Reverse Foreign Aid - Tina Rosenberg", "main": "Reverse Foreign Aid", "kicker": "Idea Lab", "print_headline": "Reverse Foreign Aid", "content_kicker": "Idea Lab"}, "abstract": null, "print_page": null, "word_count": "1498", "_id": "54905f42798810619765fb82", "snippet": "Why are poor countries subsidizing rich ones?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/03/25/magazine/25wwlnidealab.t.html", "multimedia": [{"subtype": "thumbnail", "url": "images/2007/03/25/magazine/25idea75.1.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2007/03/25/magazine/25idea75.1.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Economic Conditions and Trends", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Interest Rates", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "United Nations", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Columbia University", "is_major": "N", "rank": "4", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Tina", "lastname": "ROSENBERG"}], "original": "By TINA ROSENBERG"}, "document_type": "article", "pub_date": "2007-03-25T00:00:00Z", "section_name": "Magazine"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Doctors say the soaring cost of new vaccines makes it difficult for them to buy the shots they give their patients.", "headline": {"main": "Pediatricians Voice Anger Over Costs of Vaccines", "print_headline": "In Need of a Booster Shot"}, "abstract": null, "print_page": "1", "word_count": "1578", "_id": "54907bd779881035eeb2df11", "snippet": "Doctors say the soaring cost of new vaccines makes it difficult for them to buy the shots they give their patients.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/03/24/business/24vaccine.html", "multimedia": [{"subtype": "wide", "url": "images/2007/03/23/business/24vaccine.graphic.190.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2007/03/23/business/24vaccine.graphic.190.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2007/03/23/business/24vaccine.600.jpg", "height": 320, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2007/03/23/business/24vaccine.600.jpg", "xlargeheight": "320"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2007/03/23/business/vaccine75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2007/03/23/business/vaccine75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Vaccination and Immunization", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Doctors", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2007-03-24T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The nation's pediatricians, the foot soldiers in the campaign to vaccinate America's children, are starting to revolt. The soaring cost and rising number of new vaccines, doctors say, make it increasingly difficult for them to buy the shots they give their patients. They also complain that insurers often do not reimburse them enough, so they can lose money on every dose they deliver.", "headline": {"main": "In Need of a Booster Shot; Rising Costs Make Doctors Balk at Giving Vaccines"}, "abstract": "American pediatricians say soaring costs and rising number of new vaccines make it increasignly difficult for them to buy shots they give their patients; complain that insurers often do not reimburse them enough, so that they lose money on vaccinations; some pediatricians are not offering newest and most expensive vaccines; some public health experts say US immunization program could break down and preventable diseases could increase; photos; chart (M)", "print_page": "1", "word_count": 1578, "_id": "4fd275148eb7c8105d833e78", "snippet": "The nation's pediatricians, the foot soldiers in the campaign to vaccinate America's children, are starting to revolt.      The soaring cost and rising number of new vaccines, doctors say, make it increasingly difficult for them to buy the shots they...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9801E3D81530F937A15750C0A9619C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "VACCINATION AND IMMUNIZATION"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2007-03-24T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Eli Lilly has offered to monitor doctors to make sure they are not wasting money on mental illness drugs.", "headline": {"main": "In Some States, Maker Oversees Use of Its Drug", "print_headline": "In Some States, Maker Oversees Use of Its Drug"}, "abstract": null, "print_page": "1", "word_count": "1497", "_id": "5490788379881035eeb2dea9", "snippet": "Eli Lilly has offered to monitor doctors to make sure they are not wasting money on mental illness drugs.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/03/23/business/23lilly.html", "multimedia": [{"subtype": "xlarge", "url": "images/2007/03/23/business/23lilly.600.jpg", "height": 300, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2007/03/23/business/23lilly.600.jpg", "xlargeheight": "300"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2007/03/23/business/23lilly.75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2007/03/23/business/23lilly.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Lilly, Eli, & Co", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "States (US)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Schizophrenia", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Advertising and Marketing", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "7", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Stephanie", "lastname": "SAUL"}], "original": "By STEPHANIE SAUL"}, "document_type": "article", "pub_date": "2007-03-23T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 6, "offset": 0, "time": 40}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}